<div id="readability-page-1"><p>Procter &amp; Gamble (NYSE:PG - Get Free Report) is anticipated to issue its quarterly earnings data before the market opens  on Thursday, April 24th. Analysts expect the company to announce earnings of $1.57 per share and revenue of $20.42 billion for the quarter.  Procter &amp; Gamble has set its FY 2025 guidance at 6.910-7.050 EPS and its FY25 guidance at $6.91-$7.05 EPS.Individual interested in listening to the company's earnings conference call can do so using this link.</p><div><p><span></span><span>Get <strong>Procter &amp; Gamble</strong> alerts:</span></p></div><ul><li>3 Safe Dividend Stocks as Investors Seek to Reset Diversification</li></ul><p>Procter &amp; Gamble (NYSE:PG - Get Free Report) last released its earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter &amp; Gamble had a return on equity of 33.00% and a net margin of 18.35%. The company had revenue of $21.88 billion for the quarter, compared to analysts' expectations of $21.66 billion. During the same quarter in the previous year, the firm posted $1.84 EPS. The firm's quarterly revenue was up 2.1% on a year-over-year basis.  On average, analysts expect Procter &amp; Gamble to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year. </p><h2>Procter &amp; Gamble Trading Down 1.3 %</h2><p>Shares of PG opened at $166.32 on Thursday. The firm has a market capitalization of $390.00 billion, a P/E ratio of 26.48, a PEG ratio of 3.76 and a beta of 0.43. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The firm's 50-day moving average is $168.31 and its two-hundred day moving average is $168.54. Procter &amp; Gamble has a twelve month low of $153.52 and a twelve month high of $180.43. </p><h2>Procter &amp; Gamble Increases Dividend</h2><ul><li>The &#34;Quality&#34; Rotation: Back to Basics Investing </li></ul><p>The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Monday, April 21st will be paid a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.54%. This is a boost from Procter &amp; Gamble's previous quarterly dividend of $1.01. The ex-dividend date is Monday, April 21st. Procter &amp; Gamble's dividend payout ratio (DPR) is 67.20%. </p><h2>Insider Buying and Selling</h2><p>In other news, insider Marc S. Pritchard sold 90,450 shares of the stock in a transaction on Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total value of $14,819,328.00. Following the completion of the transaction, the insider now owns 172,814 shares in the company, valued at approximately $28,313,845.76. This represents a 34.36 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Gary A. Coombe sold 35,000 shares of the company's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $173.68, for a total transaction of $6,078,800.00. Following the completion of the sale, the chief executive officer now directly owns 22,051 shares in the company, valued at approximately $3,829,817.68. The trade was a 61.35 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 143,450 shares of company stock valued at $23,988,008. 0.18% of the stock is owned by company insiders. </p><h2>Institutional Investors Weigh In On Procter &amp; Gamble</h2><ul><li>Beyond a Market Correction, Moves to Make Now</li></ul><p>A hedge fund recently raised its stake in Procter &amp; Gamble stock. Brighton Jones LLC lifted its position in shares of  The Procter &amp; Gamble Company (NYSE:PG - Free Report) by 51.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities &amp; Exchange Commission. The fund owned 40,068 shares of the company's stock after acquiring an additional 13,617 shares during the quarter. Brighton Jones LLC's holdings in Procter &amp; Gamble were worth $6,717,000 at the end of the most recent reporting period. Institutional investors own  65.77% of the company's stock. </p><h2>Analysts Set New Price Targets</h2><p>Several equities research analysts have recently issued reports on the company. Piper Sandler decreased their price objective on Procter &amp; Gamble from $173.00 to $172.00 and set a &#34;neutral&#34; rating on the stock in a report on Monday, February 24th. DA Davidson  reissued a &#34;buy&#34; rating and issued a $209.00 target price on shares of Procter &amp; Gamble in a research report on Thursday, January 23rd. Barclays  reissued an &#34;equal weight&#34; rating on shares of Procter &amp; Gamble in a research note on Thursday, March 27th. UBS Group  reiterated a &#34;buy&#34; rating on shares of Procter &amp; Gamble in a report on Monday, February 10th. Finally, Stifel Nicolaus lifted their price objective on Procter &amp; Gamble from $161.00 to $165.00 and gave the company a &#34;hold&#34; rating in a research note on Thursday, January 23rd. Seven investment analysts have rated the stock with a hold rating, thirteen have assigned  a buy rating and three have issued  a strong buy rating to the company. According to MarketBeat, Procter &amp; Gamble presently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $181.50.</p><p><b>Check Out Our Latest Report on Procter &amp; Gamble</b></p><h2>About Procter &amp; Gamble</h2> (Get Free Report)<p>Procter &amp; Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.</p><h2>See Also</h2><ul><li>Five stocks we like better than Procter &amp; Gamble</li><li>How to Plot Fibonacci Price Inflection Levels </li><li>Viking Therapeutics Stock Pops But Struggles to Hold Gains</li><li>What is the Dogs of the Dow Strategy? Overview and Examples</li><li>Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited</li><li>What is a Bond Market Holiday? How to Invest and Trade</li><li>Meta Stock Holds Upside Potential as Analysts Cut Price Targets</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBH?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBH"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Procter &amp; Gamble Right Now?</h2><p>Before you consider Procter &amp; Gamble, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter &amp; Gamble wasn't on the list.</p><p>While Procter &amp; Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Procter & Gamble (NYSE:PG) is set to release its quarterly earnings on April 24, with analysts expecting earnings of $1.57 per share and revenue of $20.42 billion. The company has also increased its dividend to $1.0568 per share, with a yield of 2.54%. Recent insider trading saw significant share sales by executives. Institutional investors hold 65.77% of the stock, and analysts have varied price targets, with Piper Sandler lowering theirs to $172.00 while DA Davidson maintains a buy rating with a target of $209.00.</p>

Procter & Gamble (PG) to Release Earnings on Thursday